Oculis Ag

(NASDAQ) OCS

Current Price$11.11

Market Cap$634.01M

Since IPO (2021)+14%

5 YearN/A

1 Year-44%

1 Month-65%

Oculis Ag Financials at a Glance

Market Cap

$634.01M

Revenue (TTM)

CHF 504.00K

Net Income (TTM)

-CHF 95.06M

EPS (TTM)

-$2.14

P/E Ratio

-5.18

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$11.11

Volume

31,774

Open

$11.15

Price

$11.11

Volume

31,774

Open

$11.15

Previous Close

$11.11

Daily Range

$11.01 - $11.54

52-Week Range

$10.52 - $34.48

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

0.86 (Low)

Price

$11.11

Volume

31,774

Open

$11.15

Previous Close

$11.11

Daily Range

$11.01 - $11.54

52-Week Range

$10.52 - $34.48

Estimated Earnings Date

Aug 6, 2026

OCS News

Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles

Andy GouldJun 8, 2026

OCS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Oculis Ag

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Riad Sherif, MD, MBA

Website

www.oculis.com

Headquarters

Zug, 6300, CH

OCS Financials

Key Financial Metrics (TTM)

Gross Margin

-29%

Operating Margin

-167%

Net Income Margin

-189%

Return on Equity

-55%

Return on Capital

-42%

Return on Assets

-39%

Earnings Yield

-19.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$634.01M

Shares Outstanding

57.17M

Volume

31.77K

Avg. Volume

628.65K

Financials (TTM)

Gross Profit

CHF 0.00

Operating Income

-CHF 79.15M

EBITDA

-CHF 93.89M

Operating Cash Flow

-CHF 62.22M

Capital Expenditure

-CHF 287.47K

Free Cash Flow

-CHF 62.51M

Cash & ST Invst.

CHF 213.25M

Total Debt

CHF 2.32M

Oculis Ag Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

CHF 0.00

N/A

Gross Profit

-CHF 157.43K

N/A

Gross Margin

0.00%

N/A

Market Cap

$634.01M

N/A

Market Cap/Employee

$12.94M

N/A

Employees

N/A

Net Income

-CHF 29.50M

+11.2%

EBITDA

-CHF 29.26M

+10.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

CHF 221.37M

+21.7%

Total Debt

CHF 2.24M

+103.2%

Accounts Receivable

CHF 1.57M

-38.7%

Inventory

CHF 0.00

N/A

Long Term Debt

CHF 1.83M

+128.6%

Short Term Debt

CHF 414.76K

+36.4%

Return on Assets

-39.08%

N/A

Return on Invested Capital

-42.29%

N/A

Free Cash Flow

-CHF 15.54M

+22.5%

Operating Cash Flow

-CHF 15.54M

+18.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BBOTBridgeBio Oncology Therapeutics Inc.

BBOTBridgeBio Oncology Therapeutics Inc.$7.75+3.89%

SANASana Biotechnology, Inc.

SANASana Biotechnology, Inc.$2.68-3.25%

PHATPhathom Pharmaceuticals, Inc.

PHATPhathom Pharmaceuticals, Inc.$10.37+0.97%

XNCRXencor, Inc.

XNCRXencor, Inc.$12.33+1.99%

NKTRNektar Therapeutics

NKTRNektar Therapeutics$59.38+0.29%

URGNUroGen Pharma Ltd.

URGNUroGen Pharma Ltd.$29.72+0.75%

NRIXNurix Therapeutics, Inc.

NRIXNurix Therapeutics, Inc.$16.95-0.18%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About OCS

What is the current price of Oculis Ag?

Oculis Ag is trading at $11.11 per share.

What is the 52-week range for Oculis Ag?

Over the past 52 weeks, Oculis Ag has traded between $10.52 and $34.48.

How much debt does Oculis Ag have?

As of the most recent reporting period, Oculis Ag reported total debt of CHF 2.80M.

How much cash does Oculis Ag have on hand?

Oculis Ag reported CHF 80.35M in cash and cash equivalents in its most recent financial results.

What is Oculis Ag’s dividend yield?

Oculis Ag does not currently have a dividend yield.

Oculis Ag

Oculis Ag Financials at a Glance

OCS News

Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles

OCS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Oculis Ag

OCS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Oculis Ag Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About OCS

What is the current price of Oculis Ag?

What is the 52-week range for Oculis Ag?

How much debt does Oculis Ag have?

How much cash does Oculis Ag have on hand?

What is Oculis Ag’s dividend yield?

Premium Investing Services